Talking Rheumatology Research

Ep 23. The long-term use of tocilizumab in giant cell arteritis

British Society for Rheumatology

Dr Sean Gill and Dr Chetan Mukhtyar (Norfolk and Norwich University Hospital, UK) discuss the efficacy of tocilizumab for GCA, based on a 12-month extension of Stone et al.’s landmark clinical trial. Dr Mukhtyar provides an overview of the trial, including key findings, limitations, and implications for clinical practice.

Read the paper: https://doi.org/10.1093/rheumatology/keab418

Keywords: Giant cell arteritis, GCA, vasculitis, large vessel, tocilizumab, rheumatology, treatment, biologic, biological therapy, IL-6

Thanks for listening to Talking Rheumatology Research! Join the conversation on X using #TalkingRheumResearch, tweet us @RheumJnl, or find us on Instagram and LinkedIn.

Want to read more rheumatology research? Explore Rheumatology and Rheumatology Advances in Practice.